Bank Of America Corp Bicycle Therapeutics PLC Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Bank Of America Corp holds 384,865 shares of BCYC stock, worth $5.65 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

384,865

Previous 383,804 0.28%

Holding current value

$5.65 Million

Previous $7.77 Million 12.36%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$19.58 - $27.24 $20,774 - $28,901	1,061 Added 0.28%	384,865 $8.73 Million
Q2 2024 Aug 14, 2024	SELL	$20.02 - $24.69 $260,420 - $321,167	-13,008 Reduced 3.28%	383,804 $7.77 Million
Q1 2024 May 15, 2024	SELL	$16.75 - $26.1 $1.08 Million - $1.68 Million	-64,519 Reduced 13.99%	396,812 $9.88 Million
Q4 2023 Feb 14, 2024	BUY	$13.29 - $22.2 $6.04 Million - $10.1 Million	454,799 Added 6962.63%	461,331 $8.34 Million
Q2 2023 Aug 14, 2023	BUY	$18.95 - $28.67 $11,616 - $17,574	613 Added 10.36%	6,532 $166,000
Q1 2023 May 12, 2023	BUY	$20.02 - $31.37 $8,128 - $12,736	406 Added 7.36%	5,919 $125,000
Q4 2022 Feb 10, 2023	SELL	$20.37 - $32.9 $73,596 - $118,867	-3,613 Reduced 39.59%	5,513 $163,000
Q3 2022 Nov 14, 2022	SELL	$17.49 - $28.44 $142,910 - $232,383	-8,171 Reduced 47.24%	9,126 $212,000
Q2 2022 Aug 12, 2022	BUY	$12.95 - $46.99 $183,721 - $666,647	14,187 Added 456.17%	17,297 $290,000
Q1 2022 May 16, 2022	BUY	$40.12 - $59.5 $23,510 - $34,867	586 Added 23.22%	3,110 $136,000
Q4 2021 Feb 08, 2022	BUY	$41.7 - $61.14 $15,345 - $22,499	368 Added 17.07%	2,524 $153,000
Q3 2021 Nov 15, 2021	SELL	$27.95 - $44.24 $4,919 - $7,786	-176 Reduced 7.55%	2,156 $90,000
Q2 2021 Sep 13, 2021	BUY	$27.0 - $32.28 $62,964 - $75,276	2,332 New	2,332 $71,000

Others Institutions Holding BCYC

# of Institutions

111

Shares Held

40.8M

Call Options Held

39.6K

Put Options Held

24.6K

View Full List

About BICYCLE THERAPEUTICS plc

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $436M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

More about BCYC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Bicycle Therapeutics PLC Transaction History